Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 30 results.
User Information
Export Records
  1. 1.   Confidence intervals for difference in proportions for matched pairs compatible with exact McNemar's or sign tests
  2. Fay, Michael P; Lumbard,Keith
  3. Statistics in Medicine. 2020, Dec 01;
  1. 2.   APOL1 Nephropathy Risk Alleles and Risk of Sepsis in Blacks
  2. Chaudhary, Ninad S; Moore, Justin X; Zakai, Neil A; Judd, Suzanne E; Naik, Rakhi P; Limou, Sophie; Cushman, Mary; Lange, Leslie A; Wang, Henry E; Winkler,Cheryl; Irvin, Marguerite R; Kopp, Jeffrey B; Gutiérrez, Orlando M
  3. Clinical journal of the American Society of Nephrology : CJASN. 2019, Dec 6; 14(12): 1733-1740.
  1. 3.   Prednisolone pharmacokinetics in the presence and absence of Ritonavir after oral prednisone administration to healthy volunteers
  2. Penzak, S. R.; Fomnentini, E.; Alfaro, R. M.; Long, M.; Natarajan, V.; Kovacs, J.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 15; 40(5): 573-580.
  1. 4.   Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma
  2. Kovacic, M. B.; Martin, M.; Gao, X. J.; Fuksenko, T.; Chen, C. J.; Cheng, Y. J.; Chen, J. Y.; Apple, R.; Hildesheim, A.; Carrington, M.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 1): 2673-2677.
  1. 5.   Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma
  2. Ali, I. U.; Luke, B. T.; Dean, M.; Greenwald, P.
  3. British Journal of Cancer. 2005, OCT 17; 93(8): 953-959.
  1. 6.   Formylpeptide receptor FPR and the rapid growth of malignant human gliomas
  2. Zhou, Y.; Bian, X. W.; Le, Y. Y.; Gong, W. H.; Hu, J. Y.; Zhang, X.; Wang, L. H.; Iribarren, P.; Salcedo, R.; Howard, O. M. Z.; Farrar, W.; Wang, J. M.
  3. Journal of the National Cancer Institute. 2005, JUN 1; 97(11): 823-835.
  1. 7.   A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration
  2. Hageman, G. S.; Anderson, D. H.; Johnson, L. V.; Hancox, L. S.; Taiber, A. J.; Hardisty, L. I.; Hageman, J. L.; Stockman, H. A.; Borchardt, J. D.; Gehrs, K. M.; Smith, R. J. H.; Silvestri, G.; Russell, S. R.; Klaver, C. C. W.; Barbazetto, I.; Chang, S.; Yannuzzi, L. A.; Barile, G. R.; Merriam, J. C.; Smith, R. T.; Olsh, A. K.; Bergeron, J.; Zernant, J.; Merriam, J. E.; Gold, B.; Dean, M.; Allikmets, R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, MAY 17; 102(20): 7227-7232.
  1. 8.   Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer
  2. Palmieri, D.; Halverson, D. O.; Ouatas, T.; Horak, C. E.; Salerno, M.; Johnson, J.; Figg, W. D.; Hollingshead, M.; Hursting, S.; Berrigan, D.; Steinberg, S. M.; Merino, M. J.; Steeg, P. S.
  3. Journal of the National Cancer Institute. 2005, MAY 4; 97(9): 632-642.
  1. 9.   A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma
  2. Brown, E. E.; Fallin, M. D.; Goedert, J. J.; Chen, R.; Whitby, D.; Foster, C. B.; Lauria, C.; Alberg, A. J.; Messina, A.; Montella, M.; Rezza, G.; Vitale, F.; Chanock, S. J.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, MAR; 14(3): 633-637.
  1. 10.   Suboptimal prescribing in elderly outpatients: Potentially harmful drug-drug and drug-disease combinations
  2. Zhan, C. L.; Correa-de-Araujo, R.; Bierman, A. S.; Sangl, J.; Miller, M. R.; Wickizer, S. W.; Stryer, D.
  3. Journal of the American Geriatrics Society. 2005, FEB; 53(2): 262-267.
  1. 11.   Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma
  2. Huang, W. Y.; Chatterjee, N.; Chanock, S.; Dean, M.; Yeager, M.; Schoen, R. E.; Hou, L. F.; Berndt, S. I.; Yadavalli, S.; Johnson, C. C.; Hayes, R. B.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, JAN; 14(1): 152-157.
  1. 12.   The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users
  2. Duggal, P.; Winkler, C. A.; An, P.; Yu, X. F.; Farzadegan, H.; O'Brien, S. J.; Beaty, T. H.; Vlahov, D.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005 38(5): 584-589.
  1. 13.   Estrogen receptor genotypes and haplotypes associated with breast cancer risk
  2. Gold, B.; Kalush, F.; Bergeron, J.; Scott, K.; Mitra, N.; Wilson, K.; Ellis, N.; Huang, H.; Chen, M.; Lippert, R.; Halldorsson, B. V.; Woodworth, B.; White, T.; Clark, A. G.; Parl, F. F.; Broder, S.; Dean, M.; Offit, K.
  3. Cancer Research. 2004, DEC 15; 64(24): 8891-8900.
  1. 14.   CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women
  2. Yang, X. H. R.; Wacholder, S.; Xu, Z. Y.; Dean, M.; Clark, V.; Gold, B.; Brown, L. M.; Stone, B. J.; Fraumeni, J. F.; Caporaso, N. E.
  3. Cancer Letters. 2004, OCT 28; 214(2): 197-204.
  1. 15.   Mother-to-child transmission of human herpesvirus-8 in South Africa
  2. Dedicoat, M.; Newton, R.; Alkharsah, K. R.; Sheldon, J.; Szabados, I.; Ndlovu, B.; Page, T.; Casabonne, D.; Gilks, C. F.; Cassol, S. A.; Whitby, D.; Schulz, T. F.
  3. Journal of Infectious Diseases. 2004, SEP 15; 190(6): 1068-1075.
  1. 16.   The experimental antitumor agents Phortress and Doxorubicin are equiactive against human-derived breast carcinoma xenograft models
  2. Fichtner, I.; Monks, A.; Hose, C.; Stevens, M. F. G.; Bradshaw, T. D.
  3. Breast Cancer Research and Treatment. 2004, SEP; 87(1): 97-107.
  1. 17.   Global analysis of the cortical neuron proteome
  2. Yu, L. R.; Conrads, T. P.; Uo, T.; Kinoshita, Y.; Morrison, R. S.; Lucas, D. A.; Chan, K. C.; Blonder, J.; Issaq, H. J.; Veenstra, T. D.
  3. Molecular & Cellular Proteomics. 2004, SEP; 3(9): 896-907.
  1. 18.   Expressions of hepatic genes, especially IGF-binding protein-1, correlating with serum corticosterone in microarray analysis
  2. Cheng, R. Y. S.; Birely, L. A.; Lum, N. L.; Perella, C. M.; Cherry, J. M.; Bhat, N. K.; Kasprzak, K. S.; Powell, D. A.; Alvord, W. G.; Anderson, L. M.
  3. Journal of Molecular Endocrinology. 2004 32(1): 257-278.
  1. 19.   Seroprevalence of Toxoplasma gondii in American free-ranging or captive pumas (Felis concolor) and bobcats (Lynx rufus)
  2. Kikuchi, Y.; Chomel, B. B.; Kasten, R. W.; Martenson, J. S.; Swift, P. K.; O'Brien, S. J.
  3. Veterinary Parasitology. 2004 120(1-2): 1-9.
  1. 20.   Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk
  2. Peters, U.; Hayes, R. B.; Chatterjee, N.; Shao, W.; Schoen, R. E.; Pinsky, P.; Hollis, B. W.; McGlynn, K. A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2004 13(4): 546-552.
  1. 21.   Fraction of cases of acquired immunodeficiency syndrome prevented by the interactions of identified restriction gene variants
  2. Silverberg, M. J.; Smith, M. W.; Chmiel, J. S.; Detels, R.; Margolick, J. B.; Rinaldo, C. R.; O'Brien, S. J.; Munoz, A.
  3. American Journal of Epidemiology. 2004 159(3): 232-241.
  1. 22.   Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero
  2. Waalkes, M. P.; Liu, J.; Chen, H.; Xie, Y. X.; Achanzar, W. E.; Zhou, Y. S.; Cheng, M. L.; Diwan, B. A.
  3. Journal of the National Cancer Institute. 2004 96(6): 466-474.
  1. 23.   Seroprevalence of Bartonella infection in American free-ranging and captive pumas (Felis concolor) and bobcats (Lynx rufus)
  2. Chomel, B. B.; Kikuchi, Y.; Martenson, J. S.; Roelke-Parker, M. E.; Chang, C. C.; Kasten, R. W.; Foley, J. E.; Laudre, J.; Murphy, K.; Swift, P. K.; Kramer, V. L.; O'Brien, S. J.
  3. Veterinary Research. 2004, MAR-APR; 35(2): 233-241.
  1. 24.   Quantitative proteomic analysis of inorganic phosphate-induced murine MC3T3-E1 osteoblast cells
  2. Conrads, K. A.; Yu, L. R.; Lucas, D. A.; Zhou, M.; Chan, K. C.; Simpson, K. A.; Schaefer, C. F.; Issaq, H. J.; Veenstra, T. D.; Beck, G. R.; Conrads, T. P.
  3. Electrophoresis. 2004 25(9): 1342-1352.
  1. 25.   Prospective risk of cancer in CDKN2A germline mutation carriers
  2. Goldstein, A. M.; Struewing, J. P.; Fraser, M. C.; Smith, M. W.; Tucker, M. A.
  3. Journal of Medical Genetics. 2004 41(6): 421-424.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel